{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:15:17Z","timestamp":1790972117837,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T00:00:00Z","timestamp":1317945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T00:00:00Z","timestamp":1317945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1038\/leu.2011.273","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T18:58:21Z","timestamp":1318013901000},"page":"769-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-\u03b1 and cAMP\/PKA pathways"],"prefix":"10.1038","volume":"26","author":[{"given":"M","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,7]]},"reference":[{"key":"BFleu2011273_CR1","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","volume":"27","author":"MV Iorio","year":"2009","unstructured":"Iorio MV, Croce CM . MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848\u20135856.","journal-title":"J Clin Oncol"},{"key":"BFleu2011273_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee YS, Dutta A . MicroRNAs in cancer. Annu Rev Pathol 2009; 4: 199\u2013227.","journal-title":"Annu Rev Pathol"},{"key":"BFleu2011273_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrc1840","volume":"6","author":"A Esquela-Kerscher","year":"2006","unstructured":"Esquela-Kerscher A, Slack FJ . Oncomirs\u2014microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259\u2013269.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2011273_CR4","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051\u20134060.","journal-title":"EMBO J"},{"key":"BFleu2011273_CR5","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1261\/rna.7135204","volume":"10","author":"X Cai","year":"2004","unstructured":"Cai X, Hagedorn CH, Cullen BR . Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004; 10: 1957\u20131966.","journal-title":"RNA"},{"key":"BFleu2011273_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros V . The functions of animal microRNAs. Nature 2004; 431: 350\u2013355.","journal-title":"Nature"},{"key":"BFleu2011273_CR7","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1158\/0008-5472.CAN-06-2698","volume":"67","author":"A Gaur","year":"2007","unstructured":"Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007; 67: 2456\u20132468.","journal-title":"Cancer Res"},{"key":"BFleu2011273_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834\u2013838.","journal-title":"Nature"},{"key":"BFleu2011273_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ng2003","volume":"39","author":"MS Kumar","year":"2007","unstructured":"Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T . Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673\u2013677.","journal-title":"Nat Genet"},{"key":"BFleu2011273_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA . microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1\u201312.","journal-title":"Dev Biol"},{"key":"BFleu2011273_CR11","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/leu.2008.382","volume":"23","author":"S Yendamuri","year":"2009","unstructured":"Yendamuri S, Calin GA . The role of microRNA in human leukemia: a review. Leukemia 2009; 23: 1257\u20131263.","journal-title":"Leukemia"},{"key":"BFleu2011273_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MOH.0b013e328303e15d","volume":"15","author":"R Garzon","year":"2008","unstructured":"Garzon R, Croce CM . MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008; 15: 352\u2013358.","journal-title":"Curr Opin Hematol"},{"key":"BFleu2011273_CR13","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1073\/pnas.0500613102","volume":"102","author":"PS Eis","year":"2005","unstructured":"Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005; 102: 3627\u20133632.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011273_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/path.2333","volume":"215","author":"M Wang","year":"2008","unstructured":"Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC\/miR-155 expression. J Pathol 2008; 215: 13\u201320.","journal-title":"J Pathol"},{"key":"BFleu2011273_CR15","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","volume":"109","author":"L Venturini","year":"2007","unstructured":"Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007; 109: 4399\u20134405.","journal-title":"Blood"},{"key":"BFleu2011273_CR16","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1158\/0008-5472.CAN-06-4478","volume":"67","author":"S Landais","year":"2007","unstructured":"Landais S, Landry S, Legault P, Rassart E . Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 2007; 67: 5699\u20135707.","journal-title":"Cancer Res"},{"key":"BFleu2011273_CR17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP . MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83\u201386.","journal-title":"Science"},{"key":"BFleu2011273_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1600-0609.2008.01111.x","volume":"81","author":"M Merkerova","year":"2008","unstructured":"Merkerova M, Belickova M, Bruchova H . Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 2008; 81: 304\u2013310.","journal-title":"Eur J Haematol"},{"key":"BFleu2011273_CR19","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1182\/blood-2008-11-189845","volume":"113","author":"M Bellon","year":"2009","unstructured":"Bellon M, Lepelletier Y, Hermine O, Nicot C . Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood 2009; 113: 4914\u20134917.","journal-title":"Blood"},{"key":"BFleu2011273_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/embor.2008.224","volume":"10","author":"B Huang","year":"2009","unstructured":"Huang B, Zhao J, Lei Z, Shen S, Li D, Shen GX et al. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 2009; 10: 180\u2013185.","journal-title":"EMBO Rep"},{"key":"BFleu2011273_CR21","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.4049\/jimmunol.157.4.1514","volume":"157","author":"A Tamir","year":"1996","unstructured":"Tamir A, Granot Y, Isakov N . Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. J Immunol 1996; 157: 1514\u20131522.","journal-title":"J Immunol"},{"key":"BFleu2011273_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/10428190009057627","volume":"37","author":"A Lerner","year":"2000","unstructured":"Lerner A, Kim DH, Lee R . The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Leuk Lymphoma 2000; 37: 39\u201351.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2011273_CR23","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.86.22.8867","volume":"86","author":"CE Gauwerky","year":"1989","unstructured":"Gauwerky CE, Huebner K, Isobe M, Nowell PC, Croce CM . Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc Natl Acad Sci USA 1989; 86: 8867\u20138871.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011273_CR24","first-page":"D678","volume":"5","author":"BS Skalhegg","year":"2000","unstructured":"Skalhegg BS, Tasken K . Specificity in the cAMP\/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 2000; 5: D678\u2013D693.","journal-title":"Front Biosci"},{"key":"BFleu2011273_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0163-7258(00)00051-6","volume":"87","author":"F Schwede","year":"2000","unstructured":"Schwede F, Maronde E, Genieser H, Jastorff B . Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol Ther 2000; 87: 199\u2013226.","journal-title":"Pharmacol Ther"},{"key":"BFleu2011273_CR26","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1016\/S0021-9258(17)44142-1","volume":"258","author":"JD Rothermel","year":"1983","unstructured":"Rothermel JD, Stec WJ, Baraniak J, Jastorff B, Botelho LH . Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp diastereomer of adenosine cyclic 3\u2032,5\u2032-phosphorothioate. J Biol Chem 1983; 258: 12125\u201312128.","journal-title":"J Biol Chem"},{"key":"BFleu2011273_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/01.cco.0000142072.22226.09","volume":"16","author":"O Frankfurt","year":"2004","unstructured":"Frankfurt O, Rosen ST . Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 2004; 16: 553\u2013563.","journal-title":"Curr Opin Oncol"},{"key":"BFleu2011273_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0065-230X(08)00406-5","volume":"101","author":"RV Sionov","year":"2008","unstructured":"Sionov RV, Spokoini R, Kfir-Erenfeld S, Cohen O, Yefenof E . Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis. Adv Cancer Res 2008; 101: 127\u2013248.","journal-title":"Adv Cancer Res"},{"key":"BFleu2011273_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jsbmb.2004.12.017","volume":"93","author":"C Ploner","year":"2005","unstructured":"Ploner C, Schmidt S, Presul E, Renner K, Schr\u00f6cksnadel K, Rainer J et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia. J Steroid Biochem Mol Biol 2005; 93: 153\u2013160.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFleu2011273_CR30","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1096\/fj.06-6214fje","volume":"20","author":"S Schmidt","year":"2006","unstructured":"Schmidt S, Irving JA, Minto L, Matheson E, Nicholson L, Ploner A et al. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB J 2006; 20: 2600\u20132602.","journal-title":"FASEB J"},{"key":"BFleu2011273_CR31","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R . Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004; 11: S45\u2013S55.","journal-title":"Cell Death Differ"},{"key":"BFleu2011273_CR32","first-page":"3684","volume":"58","author":"RD Medh","year":"1998","unstructured":"Medh RD, Saeed MF, Johnson BH, Thompson EB . Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Cancer Res 1998; 58: 3684\u20133693.","journal-title":"Cancer Res"},{"key":"BFleu2011273_CR33","doi-asserted-by":"publisher","first-page":"37370","DOI":"10.1074\/jbc.M703697200","volume":"282","author":"Z Ji","year":"2007","unstructured":"Ji Z, Mei FC, Johnson BH, Thompson EB, Cheng X . Protein kinase A, not Epac, suppresses hedgehog activity and regulates glucocorticoid sensitivity in acute lymphoblastic leukemia cells. J Biol Chem 2007; 282: 37370\u201337377.","journal-title":"J Biol Chem"},{"key":"BFleu2011273_CR34","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1371\/journal.pone.0001020","volume":"2","author":"H Wu","year":"2007","unstructured":"Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA et al. miRNA profiling of na\u00efve, effector and memory CD8 T cells. PLoS One 2007; 2: e1020.","journal-title":"PLoS One"},{"key":"BFleu2011273_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"key":"BFleu2011273_CR36","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1210\/me.2002-0106","volume":"16","author":"MR Yudt","year":"2002","unstructured":"Yudt MR, Cidlowski JA . The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol Endocrinol 2002; 16: 1719\u20131726.","journal-title":"Mol Endocrinol"},{"key":"BFleu2011273_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1165\/rcmb.4861","volume":"27","author":"PJ Hauk","year":"2002","unstructured":"Hauk PJ, Goleva E, Strickland I, Vottero A, Chrousos GP, Kisich KO et al. Increased glucocorticoid receptor Beta expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. Am J Respir Cell Mol Biol 2002; 27: 361\u2013367.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BFleu2011273_CR38","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1158\/0008-5472.CAN-05-1227","volume":"65","author":"JA Irving","year":"2005","unstructured":"Irving JA, Minto L, Bailey S, Hall AG . Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course. Cancer Res 2005; 65: 9712\u20139718.","journal-title":"Cancer Res"},{"key":"BFleu2011273_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1182\/blood-2006-01-0261","volume":"108","author":"WJ Tissing","year":"2006","unstructured":"Tissing WJ, Meijerink JP, Brinkhof B, Broekhuis MJ, Menezes RX, den Boer ML et al. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL. Blood 2006; 108: 1045\u20131049.","journal-title":"Blood"},{"key":"BFleu2011273_CR40","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1038\/sj.cdd.4401413","volume":"11","author":"S Riml","year":"2004","unstructured":"Riml S, Schmidt S, Ausserlechner MJ, Geley S, Kofler R . Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death Differ 2004; 11: S65\u2013S72.","journal-title":"Cell Death Differ"},{"key":"BFleu2011273_CR41","first-page":"2360","volume":"93","author":"N Mori","year":"1999","unstructured":"Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW et al. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 1999; 93: 2360\u20132368.","journal-title":"Blood"},{"key":"BFleu2011273_CR42","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481\u201312486.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011273_CR43","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.1093\/nar\/gkn666","volume":"36","author":"G Gatto","year":"2008","unstructured":"Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M . Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res 2008; 36: 6608\u20136619.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2011273_CR44","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1210\/mend.12.1.0044","volume":"12","author":"LI McKay","year":"1998","unstructured":"McKay LI, Cidlowski JA . Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol 1998; 12: 45\u201356.","journal-title":"Mol Endocrinol"},{"key":"BFleu2011273_CR45","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1074\/jbc.C000526200","volume":"276","author":"Y Tao","year":"2001","unstructured":"Tao Y, Williams-Skipp C, Scheinman RI . Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. J Biol Chem 2001; 276: 2329\u20132332.","journal-title":"J Biol Chem"},{"key":"BFleu2011273_CR46","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0898-6568(00)00097-8","volume":"12","author":"C Ramstad","year":"2000","unstructured":"Ramstad C, Sundvold V, Johansen HK, Lea T . cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK\/ERK pathway. Cell Signal 2000; 12: 557\u2013563.","journal-title":"Cell Signal"},{"key":"BFleu2011273_CR47","doi-asserted-by":"publisher","first-page":"33854","DOI":"10.1074\/jbc.M104395200","volume":"276","author":"BA van Oirschot","year":"2001","unstructured":"van Oirschot BA, Stahl M, Lens SM, Medema RH . Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol Chem 2001; 276: 33854\u201333860.","journal-title":"J Biol Chem"},{"key":"BFleu2011273_CR48","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1189\/jlb.69.6.1053","volume":"69","author":"J Bodor","year":"2001","unstructured":"Bodor J, Feigenbaum L, Bodorova J, Bare C, Reitz Jr MS, Gress RE . Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J Leukoc Biol 2001; 69: 1053\u20131059.","journal-title":"J Leukoc Biol"},{"key":"BFleu2011273_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/eji.200425524","volume":"35","author":"S Minguet","year":"2005","unstructured":"Minguet S, Huber M, Rosenkranz L, Schamel WW, Reth M, Brummer T . Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur J Immunol 2005; 35: 31\u201341.","journal-title":"Eur J Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011273","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011273.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T09:08:59Z","timestamp":1686388139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["BFleu2011273"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.273","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,7]]},"assertion":[{"value":"25 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}